Hostname: page-component-8448b6f56d-c4f8m Total loading time: 0 Render date: 2024-04-24T04:50:24.878Z Has data issue: false hasContentIssue false
  • English
  • Français

Hyaluronan-coated meta-organic framework loaded with cisplatin and oleanolic acid for synergetic chemotherapy of colorectal cancer

Published online by Cambridge University Press:  29 January 2020

Qin Huang ,
En Wang ,
Weigang Gu ,
Wencong Ma  and
Yifeng Zhou
Qin Huang
Affiliation:
Department of Gastroenterology, Enze Hospital, Taizhou Enze Medical Center (Group), Taizhou, Zhejiang Province318050, China
En Wang
Affiliation:
Department of Gastroenterology, Enze Hospital, Taizhou Enze Medical Center (Group), Taizhou, Zhejiang Province318050, China
Weigang Gu
Affiliation:
Department of Gastroenterology, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province310006, China
Wencong Ma
Affiliation:
Department of Gastroenterology, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province310006, China
Yifeng Zhou*
Affiliation:
Department of Gastroenterology, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province310006, China
*
a)Address all correspondence to this author. e-mail: yifengzhou@tom.com
Get access

Abstract

Effective cancer therapy is usually limited by the off target distribution of chemotherapeutic drugs and multidrug resistance (MDR) of cancer cells. As a result, the development of a drug delivery system (DDS) capable of targeting cancer cells while at the same time delivering two or more chemotherapeutic drugs is believed to be a good solution to this dilemma. Herein, a hyaluronan-coated meta-organic framework nanoparticles (HM) were fabricated as a DDS in our study to deliver cisplatin (PDD) and oleanolic acid (Ola). Positive results were obtained in our study which reveal that the DDS (HM/PDD/Ola) is favorable in colorectal cancer (HCT116) therapy by enhancing targeted apoptosis and reversing MDR. Compared with applying free drugs or mono DDS, the dual loaded HM/PDD/Ola showed synergistic effects and better performance, which might be a future alternative for the chemotherapy of colorectal cancer.

Keywords

biomaterialnanoscalecore/shell
Type
Article
Information
Journal of Materials Research , Volume 35 , Issue 22 , 30 November 2020 , pp. 3106 - 3115
Check for updates
Copyright
Copyright © The Author(s), 2020, published on behalf of Materials Research Society by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Wang, C., Wang, Z., Zhao, X., Yu, F., Quan, Y., Cheng, Y., and Yuan, H.: DOX loaded aggregation-induced emission active polymeric nanoparticles as a fluorescence resonance energy transfer traceable drug delivery system for self-indicating cancer therapy. Acta Biomater. 85, 218 (2019).CrossRefGoogle ScholarPubMed
Meng, Z., Zhou, X., Xu, J., Han, X., Dong, Z., Wang, H., Zhang, Y., She, J., Xu, L., Wang, C., and Liu, Z.: Light-triggered in situ gelation to enable robust photodynamic-immunotherapy by repeated stimulations. Adv. Mater. 31, 1900927 (2019).CrossRefGoogle ScholarPubMed
Xiong, H., Ni, J., Jiang, Z., Tian, F., Zhou, J., and Yao, J.: Intracellular self-disassemble polysaccharide nanoassembly for multi-factors tumor drug resistance modulation of doxorubicin. Biomater. Sci. 6, 2527 (2018).CrossRefGoogle ScholarPubMed
Negi, L.M., Talegaonkar, S., Jaggi, M., and Verma, A.K.: Hyaluronated imatinib liposomes with hybrid approach to target CD44 and P-gp overexpressing MDR cancer: An in vitro, in vivo and mechanistic investigation. J. Drug Targeting 27, 183 (2019).CrossRefGoogle Scholar
Dei, S., Braconi, L., Trezza, A., Menicatti, M., Contino, M., Coronnello, M., Chiaramonte, N., Manetti, D., Perrone, M.G., Romanelli, M.N., Udomtanakunchai, C., Colabufo, N.A., Bartolucci, G., Spiga, O., Salerno, M., and Teodori, E.: Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators. Eur. J. Med. Chem. 172, 71 (2019).CrossRefGoogle ScholarPubMed
Li, S.Z., Zhao, Q., Wang, B., Yuan, S., Wang, X.Y., and Li, K.: Quercetin reversed MDR in breast cancer cells through down-regulating P-gp expression and eliminating cancer stem cells mediated by YB-1 nuclear translocation. Phytother. Res. 32, 1530 (2018).CrossRefGoogle ScholarPubMed
Zou, Z., Zou, R., Zong, D., Shi, Y., Chen, J., Huang, J., Zhu, J., Chen, L., Bao, X., Liu, Y., Liu, W., Huang, W., Hu, J., Chen, Z., Lao, X., Chen, C., Huang, X., Lu, Y., Ni, X., Fang, D., Wu, D., Lu, S., Jiang, M., Qiu, C., Wu, Y., Qiu, Q., Dong, Y., Su, Y., Zhao, C., Zhong, Z., Cai, J., and Liang, Y.: miR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression. J. Cell. Mol. Med. 21, 1929 (2017).CrossRefGoogle ScholarPubMed
Zhang, X., Li, Y., Wei, M., Liu, C., and Yang, J.: Cetuximab-modified silica nanoparticle loaded with ICG for tumor-targeted combinational therapy of breast cancer. Drug Delivery 26, 129 (2019).CrossRefGoogle ScholarPubMed
Meng, N., Zhou, Z.W., and Chen, Q.Y.: c(RGDyK) peptide-conjugated pluronic micelle for the effective delivery of epirubicin in glioblastoma: Combination of radiotherapy and chemotherapy. J. Biomater. Tissue Eng. 8, 1551 (2018).CrossRefGoogle Scholar
Zhao, X., Tang, D., Yang, T., and Wang, C.: Facile preparation of biocompatible nanostructured lipid carrier with ultra-small size as a tumor-penetration delivery system. Colloids Surf., B 170, 355 (2018).CrossRefGoogle ScholarPubMed
Xiong, H., Du, S., Zhang, P., Jiang, Z., Zhou, J., and Yao, J.: Primary tumor and pre-metastatic niches co-targeting “peptides-lego” hybrid hydroxyapatite nanoparticles for metastatic breast cancer treatment. Biomater. Sci. 6, 2591 (2018).CrossRefGoogle ScholarPubMed
Li, M., Luo, Z., and Zhao, Y.: Self-assembled hybrid nanostructures: Versatile multifunctional nanoplatforms for cancer diagnosis and therapy. Chem. Mater. 30, 25 (2018).CrossRefGoogle Scholar
Wang, C., Han, M., Liu, X., Chen, S., Hu, F., Sun, J., and Yuan, H.: Mitoxantrone-preloaded water-responsive phospholipid-amorphous calcium carbonate hybrid nanoparticles for targeted and effective cancer therapy. Int. J. Nanomed. 14, 1503 (2019).CrossRefGoogle ScholarPubMed
Wang, C., Liu, X., Chen, S., Hu, F., Sun, J., and Yuan, H.: Facile preparation of phospholipid–amorphous calcium carbonate hybrid nanoparticles: Toward controllable burst drug release and enhanced tumor penetration. Chem. Commun. 54, 13080 (2018).CrossRefGoogle ScholarPubMed
Tang, D., Zhao, X., Yang, T., and Wang, C.: Paclitaxel prodrug based mixed micelles for tumor-targeted chemotherapy. RSC Adv. 8, 380 (2018).CrossRefGoogle Scholar
Cheng, C., Meng, Y.B., Zhang, Z.H., Li, Y., Liu, C., and Zhang, Q.Q.: pH responsible and fluorescent Cy5.5-PEG-g-A-HA/CDDP complex nanoparticles: synthesis, characterization, and application for targeted drug delivery. J. Mater. Sci.: Mater. Med. 30, 1921 (2019).Google ScholarPubMed
Hu, R., Zheng, H., Cao, J., Davoudi, Z., and Wang, Q.: Synthesis and in vitro characterization of carboxymethyl chitosan-CBA-doxorubicin conjugate nanoparticles as pH-sensitive drug delivery systems. J. Biomed. Nanotechnol. 13, 1097 (2017).CrossRefGoogle ScholarPubMed
Tang, Q.S., Chen, D.Z., Xue, W.Q., Xiang, J.Y., Gong, Y.C., Zhang, L., and Guo, C.Q.: Preparation and biodistribution of 188Re-labeled folate conjugated human serum albumin magnetic cisplatin nanoparticles (188Re-folate-CDDP/HSA MNPs) in vivo. Int. J. Nanomed. 6, 3077 (2011).Google ScholarPubMed
Tu, X., Min, L.F., Chen, Q.O., Xie, M.X., and He, L.L.: Study on using magnetic iron oxide nanoparticles as HIF-1 alpha shRNA gene carrier to reverse cisplatin resistance of A549/CDDP cell lines. Prog. Biochem. Biophys. 37, 1090 (2010).CrossRefGoogle Scholar
Bao, X., Gao, M., Xu, H., Liu, K.X., Zhang, C.H., Jiang, N., Chu, Q.C., Guan, X., and Tian, Y.: A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment. Drug Dev. Ind. Pharm. 41, 1193 (2015).CrossRefGoogle ScholarPubMed
Man, D.K.W., Casettari, L., Cesp, M., Bonacucina, G., Palmieri, G.F., Sze, S.C.W., Leung, G.P.H., Lam, J.K.W., and Kwok, P.C.L.: Oleanolic acid loaded PEGylated PLA and PLGA nanoparticles with enhanced cytotoxic activity against cancer cells. Mol. Pharmaceutics 12, 2112 (2015).CrossRefGoogle ScholarPubMed
Shanmugam, M.K., Dai, X.Y., Kumar, A.P., Tan, B.K.H., Sethi, G., and Bishayee, A.: Oleanolic acid and its synthetic derivatives for the prevention and therapy of cancer: Preclinical and clinical evidence. Cancer Lett. 346, 206 (2014).CrossRefGoogle ScholarPubMed
Tan, L.W., Ma, B.Y., Zhang, L., Zhao, Q., Chen, L.J., Peng, J.R., and Qian, Z.Y.: Toxicity evaluation and anti-tumor study of docetaxel loaded mPEG-polyester micelles for breast cancer therapy. J. Biomed. Nanotechnol. 13, 393 (2017).CrossRefGoogle ScholarPubMed
Wen, L., Liang, C., Chen, E., Chen, W., Liang, F., Zhi, X., Wei, T., Xue, F., Li, G., Yang, Q., Gong, W., Feng, X., Bai, X., and Liang, T.: Regulation of multi-drug resistance in hepatocellular carcinoma cells is TRPC6/calcium dependent. Sci. Rep. 6, 23269 (2016).CrossRefGoogle ScholarPubMed
Sun, S., Gebauer, D., and Colfen, H.: A solvothermal method for synthesizing monolayer protected amorphous calcium carbonate clusters. Chem. Commun. 52, 7036 (2016).CrossRefGoogle ScholarPubMed
Vilella, A., Ruozi, B., Belletti, D., Pederzoli, F., Galliani, M., Semeghini, V., Forni, F., Zoli, M., Vandelli, M.A., and Tosi, G.: Endocytosis of nanomedicines: The case of glycopeptide engineered PLGA nanoparticles. Pharmaceutics 7, 74 (2015).CrossRefGoogle ScholarPubMed
Davis, F.M., Azimi, I., Faville, R.A., Peters, A.A., Jalink, K., Putney, J.W. Jr., Goodhill, G.J., Thompson, E.W., Roberts-Thomson, S.J., and Monteith, G.R.: Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent. Oncogene 33, 2307 (2014).CrossRefGoogle ScholarPubMed
Wang, C., Li, M., Yang, T., Ding, X., Bao, X., Ding, Y., Xiong, H., Wu, Y., Wang, W., and Zhou, J.: A self-assembled system for tumor-targeted co-delivery of drug and gene. Mater. Sci. Eng., C 56, 280 (2015).CrossRefGoogle ScholarPubMed
Hu, Z. and Deng, Y.: Superhydrophobic surface fabricated from fatty acid-modified precipitated calcium carbonate. Ind. Eng. Chem. Res. 49, 5625 (2010).CrossRefGoogle Scholar
Semalty, A., Semalty, M., Rawat, B.S., Singh, D., and Rawat, M.S.M.: Pharmacosomes: The lipid-based new drug delivery system. Expert Opin. Drug Delivery 6, 599 (2009).CrossRefGoogle ScholarPubMed
Wang, C., Yu, F., Liu, X., Chen, S., Wu, R., Zhao, R., Hu, F., and Yuan, H.: Cancer-Specific Therapy by Artificial Modulation of Intracellular Calcium Concentration. Adv. Healthcare. Mater. 8, 1900501 (2019).CrossRefGoogle Scholar
Gao, F., Zhang, J.M., Fu, C.M., Xie, X.M., Peng, F., You, J.S., Tang, H.L., Wang, Z.Y., Li, P., and Chen, J.P.: iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability. Int. J. Nanomed. 12, 4147 (2017).CrossRefGoogle ScholarPubMed
Natarajan, A., Gruettner, C., Ivkov, R., DeNardo, G.L., Mirick, G., Yuan, A., Foreman, A., and DeNardo, S.J.: NanoFerrite particle based radioimmunonanoparticles: Binding affinity and in vivo pharmacokinetics. Bioconjugate Chem. 19, 1211 (2008).CrossRefGoogle ScholarPubMed